Prodrug compounds with isoleucine

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2413149

The compounds of the invention are modified forms of therapeutic agents. A typical prodrug compound of the invention comprises a therapeutic agent, an oligopeptide having an isoleucine residue, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by an enzyme associated with the target cell. Methods of making and using the compounds are also disclosed.

L'invention concerne des composés qui sont des formes modifiées d'agents thérapeutiques. Un composé de promédicament typique décrit dans cette invention comprend un agent thérapeutique, un oligopeptide présentant un reste d'isoleucine, un groupe stabilisant, et éventuellement, un groupe de liaison. Le promédicament peut être clivé par une enzyme associée à une cellule cible. L'invention concerne également des méthodes de fabrication et d'utilisation de ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Prodrug compounds with isoleucine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prodrug compounds with isoleucine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrug compounds with isoleucine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2041859

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.